B. Riley analyst John Massocca raised the firm’s price target on Diversified Healthcare Trust (DHC) to $6.50 from $5.50 and keeps a Buy rating on the shares. Despite the recent shift of $25.8M of planned dispositions to 1Q26, the firm remains confident Diversified Healthcare Trust will have ample liquidity to address January zero-coupon debt maturity, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHC:
- Diversified Healthcare Trust Outlines 2025 Strategic Initiatives
- RBC upgrades Diversified Healthcare to Sector Perform on seniors tailwinds
- Diversified Healthcare upgraded to Sector Perform at RBC Capital
- Diversified Healthcare Trust Reports Q3 2025 Results
- Diversified Healthcare Trust’s Earnings Call: Growth Amid Challenges